Rifaximin for the treatment of recurrent Clostridium difficile infection after liver transplantation: A case series

Liver Transplantation

Volumn 16, Issue 8, 2010, Pages 960-963

  Neff, Guy ^a   Zacharias, Victoria ^a   Kaiser, Tiffany E ^a   Gaddis, Amy ^a   Kemmer, Nyingi ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METRONIDAZOLE; RIFAXIMIN; VANCOMYCIN;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CLOSTRIDIUM DIFFICILE INFECTION; DIARRHEA; DISEASE COURSE; DISEASE PREDISPOSITION; DRUG EFFICACY; FEMALE; HUMAN; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; SIDE EFFECT; TREATMENT DURATION; TREATMENT OUTCOME;

AGED; ANTI-INFECTIVE AGENTS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; FEMALE; HUMANS; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; RIFAMYCINS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77955680488     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.22092     Document Type: Article

References (16)

1. Ricciardi R, Rothenberger DA, Madoff RD, Baxter NN. Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States. Arch Surg 2007;142:624-631. (Pubitemid 47080440)
2. McFarland LV, Beneda HW, Clarridge JE, Raugi GJ. Implications of the changing face of Clostridium difficile disease for health care practitioners. Am J Infect Control 2007;35:237-253.
3. Stelzmueller I, Goegele H, Biebl M, Wiesmayr S, Berger N, Tabarelli W, et al. Clostridium difficile colitis in solid organ transplantation - a single-center experience. Dig Dis Sci 2007;52:3231-3236. (Pubitemid 47512550)
4. Albright JB, Bonatti H, Mendez J, Kramer D, Stauffer J, Hinder R, et al. Early and late onset Clostridium difficile-associated colitis following liver transplantation. Transpl Int 2007;20:856-866. (Pubitemid 47390196)
5. Singh N, Paterson DL, Gayowski T, Wagener MM, Marino IR. Predicting bacteremia and bacteremic mortality in liver transplant recipients. Liver Transpl 2000;6:54-61. (Pubitemid 30123368)
6. Ginsburg PM, Thuluvath PJ. Diarrhea in liver transplant recipients: etiology and management. Liver Transpl 2005;11:881-890. (Pubitemid 41122444)
7. Gerding DN, Muto CA, Owens RC. Treatment of Clostridium difficile infection. Clin Infect Dis 2008;46(suppl 1):S32-S42.
8. Musher DM, Aslam S, Logan N, Nallacheru S, Bhaila I, Borchert F, et al. Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole. Clin Infect Dis 2005;40:1586-1590. (Pubitemid 40720807)
9. Pépin J, Alary M-E, Valiquette L, Raiche E, Ruel J, Fulop K, et al. Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. Clin Infect Dis 2005;40:1591-1597. (Pubitemid 40720808)
10. Scarpignato C, Pelosini I. Experimental and clinical pharmacology of rifaximin, a gastrointestinal selective antibiotic. Digestion 2006;73(suppl 1):13-27. (Pubitemid 43296214)
11. Hecht DW, Galang MA, Sambol SP, Osmolski JR, Johnson S, Gerding DN. In vitro activities of 15 antimicrobial agents against 110 toxigenic Clostridium difficile clinical isolates collected from 1983 to 2004. Antimicrob Agents Chemother 2007;51:2716-2719.
12. Boero M, Berti E, Morgando A, Verme G. Treatment for colitis caused by Clostridium difficile: results of a randomized open study of rifaximine vs. vancomycin. Microbiol Med 1990;5:74-77.
13. DuPont HL, Jiang Z-D, Garey K. The oral nonsystemic antibiotic rifaximin prevents symptom recurrence in patients with recurrent Clostridium difficile-associated diarrhea [abstract]. Gastroenterology 2007;132(suppl 2):A195.
14. Johnson S, Schriever C, Galang M, Kelly CP, Gerding DN. Interruption of recurrent Clostridium difficile-associated diarrhea episodes by serial therapy with vancomycin and rifaximin. Clin Infect Dis 2007;44:846-848. (Pubitemid 46365312)
15. Johnson S, Schriever C, Patel U, Patel T, Hecht DW, Gerding DN. Rifaximin redux: treatment of recurrent Clostridium difficile infections with rifaximin immediately post-vancomycin treatment. Anaerobe 2009;15:290-291.
16. Berman AL. Efficacy of rifaximin and vancomycin combination therapy in a patient with refractory Clostridium difficile-associated diarrhea. J Clin Gastroenterol 2007;41:932-933. (Pubitemid 350307082)